Cargando…
Coagulopathies in novel coronavirus (SARS-CoV-2) pandemic: Emerging evidence for hematologists
The coronavirus disease (COVID-19), which is also known as acute respiratory syndrome coronavirus-2 (SARS-CoV2) is a transmissible disease, has phenotypes varying from asymptomatic to Acute Respiratory Distress Syndrome (ARDS) or multiple organ dysfunction syndrome (MODS) and ultimately death in cer...
Autor principal: | Al-Subaie, Abeer M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7642728/ https://www.ncbi.nlm.nih.gov/pubmed/33169062 http://dx.doi.org/10.1016/j.sjbs.2020.11.006 |
Ejemplares similares
-
SARS-CoV-2 Infected Patient: from a Hematologist’s Perspective
por: Kreidieh, Firas, et al.
Publicado: (2020) -
Coronavirus-Associated Coagulopathy: Lessons From SARS-CoV1 and MERS-CoV for the Current SARS-CoV2 Pandemic
por: Singh, Shalinder, et al.
Publicado: (2020) -
The CoV-2 outbreak: how hematologists could help to fight Covid-19
por: Galimberti, Sara, et al.
Publicado: (2020) -
A Pathophysiological Perspective on the SARS-CoV-2 Coagulopathy
por: Kusadasi, Nuray, et al.
Publicado: (2020) -
Vasculopathy and Coagulopathy Associated with SARS-CoV-2 Infection
por: Labò, Nazzarena, et al.
Publicado: (2020)